| Literature DB >> 19154345 |
Beate Spiessberger1, Dominik Bernhard, Stefan Herrmann, Susanne Feil, Claudia Werner, Peter B Luppa, Franz Hofmann.
Abstract
ACTH-stimulated aldosterone secretion can be inhibited by atrio-natriuretic peptide/cGMP. The mechanism behind this modulation has been reported to involve cGMP-dependent activation of phosphodiesterase 2 (PDE2) and hydrolysis of cAMP. Recently it was reported that activation of cGMP-dependent protein kinase II (cGKII) stimulated aldosterone secretion in rat zona glomerulosa cells. The zona glomerulosa of the murine adrenal cortex expresses cGKII and PDE2. We used mice with a homozygous inactivation of the cGKII gene to investigate in vivo the potential role of this kinase in aldosterone secretion. Basal plasma renin and aldosterone levels were similar in wild-type and cGKII(-/-) mice. In vivo injection of atrio-natriuretic peptide decreased ACTH-stimulated aldosterone secretion in wild-type mice, but had no effect in cGKII-deficient mice. These results support the view that cGKII modulates aldosterone secretion in the murine adrenal cortex.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19154345 DOI: 10.1111/j.1742-4658.2008.06839.x
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542